Avantor (AVTR) has disclosed a new risk, in the Supply Chain category.
Avantor’s operational efficiency hinges on securing high-quality raw materials that align with its stringent specifications and cost considerations, including specialized pharmaceutical ingredients and essential manufacturing components. The company faces the risk of supply chain disruptions, given its reliance on sole-sourced materials driven by market or client-specific demands. Additionally, any deviation by suppliers from Avantor’s quality and delivery expectations could compromise production timelines and profit margins, ultimately affecting the company’s financial performance adversely.
The average AVTR stock price target is $24.62, implying 0.90% upside potential.
To learn more about Avantor’s risk factors, click here.
